The global Biopsy devices market is segmented on the basis of products and geography. The report on global Biopsy devices market forecast 2012-2022 provides detailed overview and predictive analysis of the market.

The market is driven by increasing prevalence of cancer. There is constant need for high quality diagnostic and therapeutic processes. However, such unmet patient needs has forced the companies and governments to work in order to provide better services. Population aging is a major influence on patterns of health care spending in both developed and developing countries. In developed countries such as the U.S. and western European countries, where point of care healthcare services and institutional long-term care services and medcare policies are available. The proportion of aged people using healthcare services is high. The per capita health expenditure on healthcare is higher as compared to other age groups. There is constant pressure on the healthcare services as the number of older people increases. Such factors are driving the biopsy market.

Browse Full Report with Toc : http://www.briskinsights.com/report/global-biopsy-devices-market-forecast-2012-2022

Biopsy market segments include major products such guidance systems, needle based guns, needles, and forceps. Guidance systems have the highest market share amongst all the product. In 2015, guidance systems has 38% market share which expected to remain high till 2022.
Presently, North America and Europe holds the largest market share of the field i.e. more than 60% of the market total. Followed by Asia pacific.
Some of the major market players listed in the report are Angiotech, Boston Scientific, Cardinal Health, Carefusion Corp, etc.

Browse here for all category Reports : http://www.briskinsights.com/category/medical-devices-industry

SCOPE OF THE REPORT

1. Global Biopsy Devices Market By Product 2012 – 2022 ($ BILLION)
1.1. Global Needle-Based Biopsy Guns 2012 – 2022 ($ BILLION)
1.1.1. Global Vacuum-Assisted Biopsy (VAB) Devices 2012 – 2022 ($ BILLION)
1.1.2. Global Core Needle Biopsy (CNB) Devices 2012 – 2022 ($ BILLION)
1.1.3. Global Fine Needle Aspiration Biopsy (FNAB) Devices 2012 – 2022 ($ BILLION)
1.2. Global Biopsy Needles 2012 – 2022 ($ BILLION)
1.2.1. Global Disposable Biopsy Needles 2012 – 2022 ($ BILLION)
1.2.2. Global Reusable Biopsy Needles 2012 – 2022 ($ BILLION)
1.3. Global Biopsy Forceps 2012 – 2022 ($ BILLION)
1.3.1. Global Cold (General) Biopsy Forceps 2012 – 2022 ($ BILLION)
1.3.2. Global Hot Biopsy Forceps 2012 – 2022 ($ BILLION)
1.4. Global Biopsy Guidance Systems 2012 – 2022 ($ BILLION)
1.4.1. Global Manual Guidance Systems 2012 – 2022 ($ BILLION)
1.4.2. Global Robotic Guidance Systems 2012 – 2022 ($ BILLION)
1.5. Global Others 2012 – 2022 ($ BILLION)
1.5.1. Global Biopsy Brushes 2012 – 2022 ($ BILLION)
1.5.2. Global Biopsy Curettes 2012 – 2022 ($ BILLION)
1.5.3. Global Biopsy Punches 2012 – 2022 ($ BILLION)

2. Global Biopsy industry regional outlook 2012-2022 ($ billion)
2.1. North America
2.2. Europe
2.3. Asia Pacific
2.4. Middle East & Africa
2.5. Central & South America

3. Competitive Landscape
3.1. ANGIOTECH
3.2. BOSTON SCIENTIFIC
3.3. CARDINAL HEALTH
3.4. CAREFUSION CORP.
3.5. COOK MEDICAL
3.6. CR BARD
3.7. DEVICOR
3.8. DTR MEDICAL
3.9. ETHICON
3.10. FUJIFILMS HOLDINGS CORP.
3.11. HOLOGIC
3.12. MAUNA KEA TECHNOLOGIES
3.13. MDXHEALTH INC.
3.14. MITOMICS
3.15. SANARUS TECHNOLOGIES
3.16. VERNA MEDICAL TECHNOLOGIES
3.17. INRAD INC.
3.18. UK BIOPSY
3.19. INTUITIVE

For Other Research Reports: 

Blog :http://www.pdfdevices.com/global-biopsy-devices-market-is-expected-to-grow-at-the-cagr-of-9-during-2015-2022-brisk-insights/

About Us :

Brisk Insights is a global market research firm. Our insightful analysis is focused on developed and emerging markets. We identify trends and forecast markets with a view to aid businesses identify market opportunities optimize strategies.
Working in a highly dynamic and multi-dimensional business makes decision making complex. Effective business decisions are a result of the synthesis of market information. Our Research and data analysis is an efficient and cost-effective way of providing robust market analysis and can yield highly valuable intelligence relating to consumers, competitors and markets.

Contact Us :

Jennifer Smith
Office 1094
109 Vernon House
Friar Lane
Nottingham
NG1 6DQ
Phone : +448081890034 (UK)
Website : http://www.briskinsights.com/